Proton Therapy in Cancer: Global Markets to 2024HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Proton Therapy in Cancer: Global Markets to 2024GlobeNewswireJanuary 8, 2020ReblogShareTweetShareDublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "Proton Therapy in Cancer: Global Markets" report has been added to ResearchAndMarkets.com's offering. Proton Therapy in Cancer: Global Markets provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and sales through 2024.The report analyzes the market by segmenting it into the various types of room types (single-room and multi-room). The end-user markets focus on hospitals, proton therapy centers, and others. This study surveys the proton therapy market according to various types of cancers (by application) i.e. pediatric cancers, base of skull treatment, central nervous system, head and neck cancer, prostate cancer, sarcomas, lung cancer, and others.The market of proton therapy is also assessed in all the geographic regions including North America, Europe and Emerging markets. The Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.The study features new developments and patents boosting the growth of this market in the global context. A list of leading proton therapy centers, their locations, and other details are also provided.The report provides comprehensive profiles of market players in the industry. Industry structure chapter focuses on the changing market trends, leading vendors, their market shares and product offerings. This chapter also covers the mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that are expected to shape the industry.The factors such as strengths, weaknesses, threats and opportunities that are expected to play a role in the proton therapy market are evaluated in detail.The report includes:A comprehensive overview of the global markets for proton therapy or proton beam therapy (PBT) in cancer treatmentAnalyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024Coverage of historical data; effectiveness, clinical benefits and side effects (for treating malignancies) of proton technology; and key role plays across various cancersRetrospective study outlining difference between proton-based therapy and conventional intensity modulated radiation therapy (IMRT), cost effectiveness for specific patients such as children, and clinical advances in hematology and oncologyAssessment of recent breakthroughs, current R&D activities, rapid technological advances in PBT, expanding utilization of image-guided proton therapy, and latest trends related to this field of clinical researchPatent review and new developments in PBT technologiesCompany profiles of leading market participants within the industry, including Elekta Instrument AB, Hitachi, Ltd., Mevion Medical Systems, Inc., Pronova Solutions, Llc, Protom International, Raysearch Laboratories Ab and Varian Medical Systems, Inc.Key Topics Covered
Chapter 1 IntroductionStudy Goals and Objectives Reasons for Doing This StudyScope of ReportInformation SourcesMethodology Geographic BreakdownChapter 2 Summary and HighlightsKey Highlights of the Report Chapter 3 Market and Technology BackgroundHistory of Proton TherapyPrinciples of Proton TherapyProton Therapy TechnologyParticle AcceleratorBeam Transport SystemBeam Delivery SystemProton Delivery TechniquesPatient Positioning SystemsTreatment RoomsTreatment Planning in Proton TherapyTreatment Planning SoftwareSide Effects of Proton TherapyTechnical Limitations of Proton TherapyUncertainty in dose distribution:Correct patient positioning:Differing values of RBE:Role of Proton Therapy Across Various CancersPediatric CancerBase of Skull TumorsCentral Nervous System (CNS) CancerHead and Neck CancerProstate CancerLung CancerOthers (Gastrointestinal Cancer, Cancer of Connective Tissues and Bone or Sarcomas, Breast Cancer)Regulations Affecting Proton Therapy SystemsChapter 4 Market Breakdown by Technology Type Market by Room TypeMarket OverviewMarket RevenueMarket SharesMarket by Technology TypeMarket OverviewMarket RevenueMarket SharesAccelerators MarketBeam Delivery Systems MarketTreatment Planning Software MarketServices MarketChapter 5 Market Breakdown by RegionInsurance and Reimbursement for Proton TherapyNorth AmericaEuropeEmerging MarketsMarket by RegionMarket RevenueMarket SharesSingle Room Proton Therapy MarketMarket RevenueMulti-Room Proton Therapy MarketMarket RevenueAccelerators MarketMarket RevenueMarket SharesCyclotronsMarket RevenueSynchrotronsMarket RevenueBeam Delivery Systems MarketMarket RevenueMarket SharesIsocentric GantriesMarket RevenueFixed Beam SystemsMarket RevenueTreatment Planning Software MarketMarket RevenueMarket SharesServices MarketMarket RevenueMarket SharesChapter 6 Market Breakdown by End UserMarket Analysis by End-UsersMarket RevenueEnd-Users by RegionProton Therapy CentersHospitalsUniversitiesChapter 7 Market Breakdown by ApplicationMarket Analysis by ApplicationsMarket RevenueMarket ShareProstate CancerMarket RevenueBreast CancerLung CancerHead and Neck CancerCentral Nervous System (CNS) CancerBase of Skull CancerPediatric CancerOther CancersChapter 8 Industry StructureProton Therapy Rooms Collaborations and PartnershipsMergers and AcquisitionsLeading Manufacturers/Suppliers in the Global Proton Therapy MarketAcceleratorsBeam Delivery SystemsTreatment Planning SoftwareServicesChapter 9 Clinical Trials in Proton TherapyClinical Trials by Type of CancerClinical Trials by Status of the StudyClinical Trials by CountryClinical Trials by Sponsor/CollaboratorChapter 10 Proton Therapy Centers and Patient VolumeStruggle for Proton Therapy CentersFight Back for Proton Therapy CentersProton Therapy Centers in North AmericaProton Therapy Centers in European UnionProton Therapy Centers in Other RegionsPatient Treatment VolumeTop 10 PTCs in the U.S. and Outside U.S.Chapter 11 Patent AnalysisPatent AnalysisPatents by YearPatents by TypePatents by Company Patents by CountryPatents by AssigneeChapter 12 Analysis of Market OpportunitiesStrengths of Proton Therapy MarketGrowing Incidence of CancerTechnological Advances in Proton TherapyGrowing Clinical Evidence Challenges for Proton Therapy MarketRequirement of Skilled LaborCost of Equipment and FacilitiesReimbursement PoliciesDifficulty in Enrollment in Clinical TrialsOpportunities for Proton Therapy MarketEmerging MarketsImprovement in Reimbursement PoliciesImprovement in TechnologyThreats for Proton Therapy MarketCompeting TechnologiesChapter 13 Company ProfilesElekta Instrument ABHitachi Ltd.Ion Beam Applications SA (IBA)Koninklijke Philips N.V.Mevion Medical Systems Inc.Pronova Solutions LLCProtom InternationalRaysearch Laboratories ABSumitomo Heavy Industries Ltd.Varian Medical Systems Inc.For more information about this report visit https://www.researchandmarkets.com/r/oo1ds5Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextCancer daily horoscopeEllePost 9/11 veterans attribute deadly cancers to contaminants at US base in UzbekistanMilitary TimesParents of two-year-old boy with cancer face deportation after being denied deferred action grantThe IndependentShould You Have a Lung Cancer Screening?Consumer ReportsHospital Staff Helps Organize 'Bittersweet' Wedding for Terminally Ill Patient and His FiancéePeopleBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloomberg